Treatment with p38γ/p38δ inhibitor shows antifungal effects in vivo Treatment with p38γ/p38δ inhibitor shows antifungal effects in vivo WT mice were intravenously injected with 1 × 105 CFU of Candida albicans and treated with 10 mg BIRB796 or SB203580 per kg body weight per day, or with the same volume of the vehicle DMSO. Kidney fungal load was determined 3 days after infection. ns, not significant, *P ≤ 0.05 (n = 5 mice/condition). Each symbol represents an individual mouse. Parametric, unpaired t‐test.Mice were treated as in (A) and iNOS mRNA levels in the kidney measured 3 days after infection by qPCR. Each symbol represents an individual mouse. Figure shows mean ± SEM (n = 5 mice/condition). ns, not significant, *P ≤ 0.05. Parametric, unpaired t‐test.Neutrophil infiltration in the kidney of infected WT mice, treated with BIRB796 or SB203580 inhibitor as in (A) was determined by flow cytometry. Each symbol represents an individual mouse. Figure shows mean ± SEM (n = 6 mice/condition), ns not significant; ***P ≤ 0.001. Parametric, unpaired t‐test.Mice were intraperitoneally infected with 5 × 106 CFU C. albicans and treated with 10 mg/kg body weight per day BIRB796 or SB203580, or with the same volume of the vehicle DMSO. Neutrophil infiltration in the peritoneum was measured by flow cytometry at day 1 post‐infection. Each symbol represents an individual mouse. Figure shows mean ± SEM (n = 4 mice/condition), ns, not significant; *P ≤ 0.05, **P ≤ 0.01. Parametric, unpaired t‐test. Dayanira Alsina‐Beauchamp et al. EMBO Mol Med. 2018;emmm.201708485 © as stated in the article, figure or figure legend